We report the antibiofilm activity by the sponge-associated bacterium Cobetia marina upon Staphylococcus epidermidis clinical isolates obtained from central venous catheters. Antibiofilm activity/antimicrobial susceptibility correlation might predict the action of the metabolite(s) upon Staphylococcus epidermidis in the clinic, making it a possible adjuvant in therapies against biofilm-associated infections.
Medical device-related infections represent a serious clinical problem, since the majority of hospital patients undergo procedures for the insertion of foreign devices. Indeed, staphylococcal implant-related infections are the prototype of a biofilm infection and coagulase-negative staphylococci, mainly Staphylococcus epidermidis, predominate as the agent of these biomedical infections (11, 12) . Once the biofilm is established, therapeutic options become limited due to difficulties with the perfusion of antimicrobial agents into biofilm and to the metabolic latent state of bacteria in the biofilm lifestyle. Thus, interference with cell-cell signaling by modulating quorum sensing (QS) to prevent biofilm formation might be an attractive strategy to treat these infections. In this alternative approach, which does not interfere with bacterial growth, the switching off of virulence expression and attenuation of the pathogen make microorganisms more susceptible to antimicrobials and to the immune system (9).
The potential advantages of antivirulence therapies include the large number of bacterial functions that can be inhibited, the preservation of normal human microbiota and the reduction in selective pressure that may result in decreased resistance (4) .
Marine sponges are reservoirs of microorganisms and their survival in this particular environment resulted in the ability to produce unique compounds as a manner of combating enemies (16) , an ability which we wanted to exploit in order to target pathogenic biofilms. To our knowledge this is the first report on the production of culture filtrate obtained from the marine Gramnegative bacterium Cobetia marina, which interferes significantly in S. epidermidis biofilm formation. Inc., NY, USA) were used. In the (i) antibiofilm formation assay, 100 µL of bacterial suspension, 100 µL of 224CF and 50 µL of LB were incubated at 37 °C for 24 h to S. epidermidis, and for 8 h to P. aeruginosa, while in the (ii) biofilm eradication assay we added 100 µL of 224CF and 100 µL of LB after the period of biofilm formation. Afterwards, in both protocols, the wells were washed and heat-fixed by exposing them to hot air at 60 °C for 1 h. The adherent biofilm layer formed was stained with 0.4% crystal violet for 15 min.
The stain was rinsed off, resolubilized with DMSO (Sigma, St.
Louis, MO, USA) and absorbance was measured at 570 nm (Spectramax M2e, Molecular Devices, CA, USA). The biofilm formation control was considered to represent 100% of biofilm formation, and the 224CF was replaced by 100 µL of LB.
Antibacterial assays were performed by measuring the bacterial growth (OD 600 ). As control, the culture filtrate was replaced by 100 µL of LB and was considered 100% of planktonic bacterial growth.
The strains were classified in the biofilm assay as described earlier (15) 
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Results represent mean ± standard deviation of 3 experiments. * represents significant difference in relation to control (p < 0.05). M and W represent moderate and weak biofilm producers, respectively. R represents resistant and S represents sensitive to the respective antibiotic; CL= clindamycin; GN= gentamicin; RF= rifampicin; A/C= amoxycillin/clavulanate; OX= oxacillin; A/S= ampicillin/sulbactam; CZ= cefazolin; CX= ceftriaxone; CP= ciprofloxacin; LV= levofloxacin and NO= norfloxacin.
Statistical analysis
All experiments were performed at least in triplicate and analyzed by Student's t-Test using SPSS 12.0 software.
Analysis and correlations involving clinical isolates were done using Statistica 9.0.
Scanning electron microscopy (SEM)
S. epidermidis ATCC 35984 was grown in sterile 96-well microtiter plates holding pieces of glass coverslips, using LB medium in the untreated biofilm (control) and 224CF in the treated group for 24 h at 37 °C. Samples were prepared as Antibiofilm activity of C. marina EPS can vary greatly between biofilms, depending on the microorganisms present, the shear forces experienced, the temperature and the availability of nutrients (6).
Poly-N-acetylglucosamine is considered the main component of staphylococcal matrix, but proteins and extracellular teichoic acid also are present (8) . Nevertheless, P. aeruginosa EPS may contains alginate, Pel (from pellicles) -a glucose-rich matrix polysaccharide polymer and Psl (from polysaccharide synthesis locus) -a mannose-rich and galactose-rich polysaccharide (14) .
The presence of two distinct molecules in the filtrate affecting S. epidermidis and P. aeruginosa separately or the marked difference in the EPS composition could explain the 224CF activity upon each bacterium. It is known that there is a connection existing between cell density and the EPS production, which is QS-regulated (10). Thus, it might be possible that 224CF is able to modulate the QS of S. epidermidis and thereby prevent EPS production, blocking the irreversible adhesion to a surface and, consequently, the formation of biofilm. 
